文献速递主动脉疾病

高容量主动脉中心EVAR失败后开放转换的当代结局

Contemporary outcomes of open conversion after failed endovascular aortic aneurysm repair from a high-volume aortic center.
PubMed 文献 · J Vasc Surg · 2026-03-06

单中心回顾2002—2025年294例EVAR失败后开放转换(EVAR-c),其中择期193例(66%)、非择期101例(34%)。非择期指征以破裂(54%)为主,择期以內漏(85%)为主。总体30天死亡率为10%,非择期19%对择期5%(P<.001);择期EVAR-c在高容量中心可实现低死亡率与可接受并发症。

要点

  • 非择期EVAR-c 30天死亡率为19%,显著高于择期的5%(P<.001)。
  • 择期转换多因內漏(85%),且距初次EVAR时间更长(中位60个月)。
  • 非择期手术需更多复杂重建、失血量更大、住院更久,应尽早转诊择期处理。

核心结论

  • EVAR-c资源消耗大、并发症率高、住院时间长,非择期尤为突出。
  • 在经验丰富的中心,择期EVAR-c可实现低死亡率与可接受的并发症率。
  • 择期与非择期代表不同临床表型,需早期发现失败EVAR并及时转诊至专科中心。

研究设计与样本

  • 单中心高容量主动脉中心2002—2025年所有EVAR-c的回顾性综述。
  • 共294例EVAR-c,择期193例(66%),非择期101例(34%)。
  • 非择期定义为破裂、术中转换、感染和/或主动脉肠瘘;主要结局为30天死亡率。

主要发现

  • 非择期指征:破裂54%、霉菌性动脉瘤32%、主动脉肠瘘10%、术中转换4%。
  • 择期指征以內漏为主(85%;其中1a/1b型70%)。
  • 择期EVAR-c距初次EVAR中位60个月(IQR 31-105),非择期中位34个月(IQR 6-73;P<.001)。
  • 总体30天死亡率10%(非择期19%对择期5%;P<.001),90天死亡率25%对10%(P=.001)。
  • 主要并发症63%(非择期79%对择期55%;P<.001);5年生存非择期66%±5%、择期80%±3%(log-rank P=.007)。

关键数值与推荐

  • 非择期肠或肢体缺血9%对择期2%(P=.004),新需血液透析15%对6%(P=.02)。
  • 非择期肠系膜上动脉以上阻断67%对50%(P=.006),全移植物取出59%对21%(P<.001)。
  • 非择期失血3.0对2.0 L(P<.001),输血5单位(IQR 3-8)对2单位(IQR 0-3;P<.001)。
  • 非择期手术时间4.4小时(IQR 3.0-5.4)对3.2小时(IQR 2.5-4.5;P<.001)。
  • 中位住院11天(IQR 8-17),非择期14天对择期10天(P<.001)。

临床怎么用

  • 对EVAR术后随访应早期识别內漏等失败征象,及时转诊择期转换。
  • 择期EVAR-c应集中在具备高容量主动脉手术经验的中心开展。
  • 非择期EVAR-c需按复杂重建准备,预估大失血、输血与延长住院资源。

局限性

  • 为单中心高容量主动脉中心的回顾性研究,结果外推需谨慎。
  • 择期与非择期为非随机分组,组间基线差异可能影响结局比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Open conversion after failed endovascular aneurysm repair (EVAR-c) is associated with higher morbidity and mortality relative to native open aneurysm repair, particularly in non-elective settings. These concerns drive enthusiasm for endovascular salvage strategies; however, high-volume aortic centers can achieve excellent open abdominal aortic aneurysm (AAA) outcomes, potentially influencing EVAR-c results. Although worse outcomes are expected after non-elective presentations, comparing elective and non-elective EVAR-c highlights distinct patient phenotypes, technical demands, and outcome profiles that can guide management. We reviewed our single-center experience to characterize operative strategies, complications, and survival after EVAR-c. METHODS: A retrospective review of all EVAR-c performed at our high-volume aortic center (2002-2025) was performed. Patients were stratified as elective or non-elective (rupture, intraoperative conversion, infection, and/or aorto-enteric fistula). The primary outcome was 30-day mortality. Secondary outcomes included postoperative complications, 90-day mortality, discharge disposition, and long-term survival. RESULTS: Among 294 EVAR-c procedures, 193 (66%) were elective and 101 (34%) were non-elective. The median age was 73 years, and 84% were male, with comparable comorbidity profiles between groups. Non-elective indications included rupture (54%), mycotic aneurysm (32%), aorto-enteric fistula (10%), and intraoperative conversion (4%). Elective conversions were predominantly for endoleak (85%; type 1a/1b in 70%). Elective EVAR-c occurred later after the index endovascular aneurysm repair (EVAR) (60 months; interquartile range [IQR], 31-105 months) vs non-elective (34 months; IQR, 6-73 months; P < .001). Non-elective procedures involved more complex reconstructions, including higher rates of supra-mesenteric cross-clamping (67% vs 50%; P = .006), total graft explant (59% vs 21%; P < .001), and adjunctive intraoperative procedures (49% vs 30%; P = .002). They were also associated with greater blood loss (3.0 vs 2.0 L; P < .001), higher transfusion requirements (5 units [IQR, 3-8 units] vs 2 units [IQR, 0-3 units]; P < .001), and longer operative times (4.4 hours [IQR, 3.0-5.4 hours] vs 3.2 hours [IQR, 2.5-4.5 hours]; P < .001). Overall 30-day mortality was 10% (non-elective, 19% vs elective, 5%; P < .001). Ninety-day mortality was 25% vs 10% (P = .001). Median length of stay was 11 days [IQR, 8-17 days] (non-elective 14 vs elective 10 days; P < .001). Major complications occurred in 63% of patients, more frequently after non-elective EVAR-c (79% vs 55%; P < .001), including bowel or limb ischemia (9% vs 2%; P = .004) and new hemodialysis requirement (15% vs 6%; P = .02). Five-year survival was 66% ± 5% for non-elective and 80% ± 3% for elective procedures, with similar trajectories beyond 90 days (log-rank P = .007). CONCLUSIONS: EVAR-c is resource-intensive and associated with high complication rates and prolonged hospitalization, particularly after non-elective presentations. Elective EVAR-c, however, can be performed with low mortality and acceptable morbidity at experienced centers. Although elective and non-elective procedures represent distinct clinical phenotypes with different technical challenges and resource requirements, these data underscore the importance of early detection of failing EVAR, timely referral for elective conversion, and centralization of care in specialized aortic centers to optimize outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Fassler MJ, Scali ST, Stinson GP, et al. Contemporary outcomes of open conversion after failed endovascular aortic aneurysm repair from a high-volume aortic center. J Vasc Surg. 2026. PMID: 41794195. doi:10.1016/j.jvs.2026.02.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。